These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22386420)

  • 21. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia.
    Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Wolfert RL; Marks LS; Song W; Wheeler TM; Slawin KM
    Urology; 2000 Jan; 55(1):41-5. PubMed ID: 10654892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal changes in peak urinary flow rates in a community based cohort.
    Roberts RO; Jacobsen SJ; Jacobson DJ; Rhodes T; Girman CJ; Lieber MM
    J Urol; 2000 Jan; 163(1):107-13. PubMed ID: 10604326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection.
    Wallner LP; Morgenstern H; McGree ME; Jacobson DJ; St Sauver JL; Jacobsen SJ; Sarma AV
    Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):501-8. PubMed ID: 21242331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent advances in proPSA on early detection in prostate cancer].
    Zhu PY; Hong P; Huang YF
    Zhonghua Nan Ke Xue; 2005 Dec; 11(12):944-6. PubMed ID: 16398372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [[-2] proPSA: A Novel Marker of Prostate Cancer].
    Ishikura K
    Rinsho Byori; 2015 Jan; 63(1):84-93. PubMed ID: 26524883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
    Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
    JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis.
    Filella X; Giménez N
    Clin Chem Lab Med; 2013 Apr; 51(4):729-39. PubMed ID: 23154423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore Longitudinal Study of Aging.
    Wright EJ; Fang J; Metter EJ; Partin AW; Landis P; Chan D; Carter H
    J Urol; 2002 Jun; 167(6):2484-7; discussion 2487-8. PubMed ID: 11992063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancer.
    Stephan C; Meyer HA; Paul EM; Kristiansen G; Loening SA; Lein M; Jung K
    Anticancer Res; 2007; 27(4A):1833-6. PubMed ID: 17649780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer].
    Lamy PJ; Montels F; Tosi D; Leizour B; Bascoul-Mollevi C; Castan F; Roques S; Nielloud F; Rebillard X
    Ann Biol Clin (Paris); 2013; 71(5):537-44. PubMed ID: 24113439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of precursor prostate-specific antigen isoform ratios in the detection of prostate cancer.
    Naya Y; Fritsche HA; Bhadkamkar VA; Mikolajczyk SD; Rittenhouse HG; Babaian RJ
    Urol Oncol; 2005; 23(1):16-21. PubMed ID: 15885578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign prostatic hyperplasia-associated prostate-specific antigen (BPSA) shows unique immunoreactivity with anti-PSA monoclonal antibodies.
    Wang TJ; Slawin KM; Rittenhouse HG; Millar LS; Mikolajczyk SD
    Eur J Biochem; 2000 Jul; 267(13):4040-5. PubMed ID: 10866804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation step.
    Niemelä P; Lövgren J; Karp M; Lilja H; Pettersson K
    Clin Chem; 2002 Aug; 48(8):1257-64. PubMed ID: 12142382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination.
    Lazzeri M; Abrate A; Lughezzani G; Gadda GM; Freschi M; Mistretta F; Lista G; Fossati N; Larcher A; Kinzikeeva E; Buffi N; Dell'Acqua V; Bini V; Montorsi F; Guazzoni G
    Urology; 2014 Mar; 83(3):606-12. PubMed ID: 24315305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study.
    Roehrborn CG; McConnell J; Bonilla J; Rosenblatt S; Hudson PB; Malek GH; Schellhammer PF; Bruskewitz R; Matsumoto AM; Harrison LH; Fuselier HA; Walsh P; Roy J; Andriole G; Resnick M; Waldstreicher J
    J Urol; 2000 Jan; 163(1):13-20. PubMed ID: 10604304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?
    Carter HB; Landis P; Wright EJ; Parsons JK; Metter EJ
    J Urol; 2005 Jun; 173(6):2040-3. PubMed ID: 15879821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status.
    Jacobsen SJ; Jacobson DJ; Girman CJ; Roberts RO; Rhodes T; Guess HA; Lieber MM
    J Urol; 1999 Oct; 162(4):1301-6. PubMed ID: 10492184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men.
    Sarma AV; Jacobsen SJ; Girman CJ; Jacobson DJ; Roberts RO; Rhodes T; Lieber M
    J Urol; 2002 Oct; 168(4 Pt 1):1446-52. PubMed ID: 12352415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of benign prostatic enlargement: long-term longitudinal population-based study of prostate volume doubling times.
    Lieber MM; Rhodes T; Jacobson DJ; McGree ME; Girman CJ; Jacobsen SJ; St Sauver JL
    BJU Int; 2010 Jan; 105(2):214-9. PubMed ID: 19594737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical staining of precursor forms of prostate-specific antigen (proPSA) in metastatic prostate cancer.
    Parwani AV; Marlow C; Demarzo AM; Mikolajczyk SD; Rittenhouse HG; Veltri RW; Chan TY
    Am J Surg Pathol; 2006 Oct; 30(10):1231-6. PubMed ID: 17001152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.